{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-073129","form_type":"8-K","ticker":"TRVI","cik":"0001563880","company_name":"Trevi Therapeutics, Inc.","filed_at":"2024-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.974720+00:00","generated_at":"2026-06-01T04:36:13.949138+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Trevi Therapeutics annual meeting results: all director nominees elected, auditor ratified","bullets":["Dominick Colangelo re-elected as Class II director with 47.1M votes for (99.8% of votes cast).","Edward Mathers re-elected with 32.7M for; David Meeker re-elected with 33.6M for.","Ernst & Young ratified as independent auditor for FY2024 with 54.0M for (99.9% of votes cast)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-073129","json":"https://secwatch.observer/filing/0000950170-24-073129.json","markdown":"https://secwatch.observer/filing/0000950170-24-073129.md","text":"https://secwatch.observer/filing/0000950170-24-073129.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563880/000095017024073129/0000950170-24-073129-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563880/000095017024073129/trvi-20240613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:36:13.949138+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}